Antimicrobial Resistance
AMR is threatening human and animal health as well as the environment. The consequences of inaction are too grave to contemplate.
About the AMR Stakeholder Network
Publications
NAPs: Translating political commitments into action
Indicators for the surveillance of AMR and antimicrobial consumption
EU law and competence to tackle antimicrobial resistance: What can the EU do?
Latest Developments
EPHA joins call on the European Commission for immediate action on the threats from pharmaceutical pollution
5 concrete measures for the European Commission to take immediately to protect public and environmental health.
read moreAmbition versus compromise: is the European Union’s Strategic Approach to Pharmaceuticals in the Environment robust enough?
The Commission’s Strategic Approach ignores existing evidence and continues to postpone action.
read moreEPHA co-signs response to the public consultation on draft recommendations of the Inter-Agency Coordination Group on AMR
An urgent response to the challenge of AMR, increased investment, measurable targets and accountability mechanisms are needed.
read moreAnalysis & Opinion
UK action on AMR: pushing for an antibiotic de-linkage model
The new UK national action plan on AMR takes things further by offering a “fully integrated and aligned” One Health approach covering health, animals, the environment and the food chain.
read moreAddress pharmaceutical pollution now to stop antimicrobial resistance
Tackling pharmaceutical pollution in the environment is crucial is we are to tackle the threat of antimicrobial resistance
read moreAMR:Getting the basics right
What are the challenges facing the nursing profession in tackling antimicrobial resistance?
read morePast Events
Invest and Protect
7 May 2019Sustainable financing to tackle AMR. What can the EU do to support Member States’ efforts to tackle AMR nationally, regionally and locally?
Joining the dots
30 January 2018Tackling AMR and environmental pollution caused by pharmaceutical consumption in Europe and by the production process of antibiotics in third countries.
Do you have a question?
Meet our AMR Policy Leads and Scientific Advisors.
Ann-Marie Borg
Policy Coordinator
ann-marie@epha.org
+32 (0) 2 233 3877
Rose Gallagher MBE
EPHA Scientific Advisor on AMR
Professional Lead Infection Prevention & Control, Royal College of Nursing (UK)